The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tislelizumab combined with nab-paclitaxel single-agent chemotherapy plus bevacizumab for patients with EGFR-TKIs-resistant advanced NSCLC with ECOG PS 0-2.
 
Xiaohong Xie
No Relationships to Disclose
 
MaoLin Zhou
No Relationships to Disclose
 
YiLin Yang
No Relationships to Disclose
 
Xinqing Lin
No Relationships to Disclose
 
Zhanhong Xie
No Relationships to Disclose
 
Yinyin Qin
No Relationships to Disclose
 
Jiexia Zhang
No Relationships to Disclose
 
Ming Liu
No Relationships to Disclose
 
Ru Li
No Relationships to Disclose
 
ChengZhi Zhou
No Relationships to Disclose